New JAK Inhibitor Shows Promise in Refractory RA (CME/CE)

(MedPage Today) -- No dose-related adverse events seen with peficitinib
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news
More News: Geriatrics